Elsevier’s 2027 Intravenous Medications
- 43rd Edition - March 28, 2026
- Latest edition
- Author: Shelly Rainforth Collins
- Language: English
**Selected for 2026 Doody's Core Titles as an Essential Purchase in Medical/Surgical**Find the essential information you need to safely administer more than 400 intravenous drugs!… Read more
Purchase options
Description
Description
**Selected for 2026 Doody's Core Titles as an Essential Purchase in Medical/Surgical**
Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elsevier’s 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elsevier’s 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Key features
Key features
- Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference
- Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds
- Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more
- 50-year history of impeccable accuracy reinforces the importance of safe IV drug administration
- Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page
- Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks
- Blue-screened text calls attention to other circumstances not covered by Black Box Warnings
- Dosage and dilution charts within monographs provide quick summaries of essential clinical information
- Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients
- Additional drug monographs are provided on the companion Evolve website
Readership
Readership
Undergraduate and graduate nursing students
Table of contents
Table of contents
General Dilution Charts
How to Use This Book
Evolve Website Information
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
IV Drugs
Alphabetical Drug Monographs
Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
Appendix B: FDA Pregnancy Categories
Appendix C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
Appendix D: Information for Patients Receiving Immunosuppressive Agents
Appendix E: Recently Approved Drugs
Index
How to Use This Book
Evolve Website Information
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
IV Drugs
Alphabetical Drug Monographs
Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
Appendix B: FDA Pregnancy Categories
Appendix C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
Appendix D: Information for Patients Receiving Immunosuppressive Agents
Appendix E: Recently Approved Drugs
Index
Product details
Product details
- Edition: 43
- Latest edition
- Published: June 11, 2026
- Language: English
About the author
About the author
SC
Shelly Rainforth Collins
Shelly Collins, PharmD, has decades of clinical experience in which she has been responsible for overseeing system-wide pharmaceutical safety.
Affiliations and expertise
President, Drug Information Consultants, Chesapeake, Virginia, USA